EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Practical synthesis and regioselective alkylation of methyl-4(5)-(pentafluoroethyl)-2-propylimidazole-5(4)-carboxylate to give DuP 532, a potent angiotensin II antagonist


Journal of Organic Chemistry 58(17): 4642-4645
Practical synthesis and regioselective alkylation of methyl-4(5)-(pentafluoroethyl)-2-propylimidazole-5(4)-carboxylate to give DuP 532, a potent angiotensin II antagonist
DuP 532 (2), which is a potent angiotensin II receptor antagonist, has been prepared by two different routes. One route, which is more practical for large-scale synthesis, required the preparation of methyl 4(5)-(pentafluoroethyl)-2-propylimidazole-5(4)-carboxylate (9). This imidazole was synthesized in five steps from commercially available 11 in 32% overall yield. Alternate perfluoroalkylation methods of the iodoimidazole precursor 14 are presented.

(PDF 0-2 workdays service: $29.90)

Accession: 009224584



Related references

Practical synthesis and regioselective alkylation of methyl-4 - -2-propylimidazole-5 -carboxylate to give DuP 532, a potent angiotensin II antagonist. Journal of Organic Chemistry 58(17): 4642-4645, 1993

Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, -1- ethyl 2-ethoxy-1- bipenyl-4-yl-methyl-1H-benzimidazole-7-carboxylate. Journal of Pharmacology & Experimental Therapeutics 268(3): 1540-1547, 1994

Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 268(3): 1540-1547, 1994

Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (racemic)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)bipenyl-4-yl)-methyl)-1H-benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 268(3): 1540-1547, 1994

Synthesis of KT3-671, 2-propyl-8-oxo-1 biphenyl-4-yl methyl-4,5,6,7-tetrahydro-cycloheptimidazole, a novel potent nonpeptide angiotensin II receptor antagonist. Journal of Labelled Compounds & Radiopharmaceuticals 36(10): 915-919, 1995

Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). Journal of Pharmacology and Experimental Therapeutics 266(1): 114-120, 1993

Synthesis of (14C)KT3-671, 2-propyl-8-oxo-1((2'-(1H-(14C) tetrazole-5-yl) biphenyl-4-yl) methyl)-4,5,6,7-tetrahydro-cycloheptimidazole, a novel potent nonpeptide angiotensin II receptor antagonist. Journal of Labelled Compounds and Radiopharmaceuticals 36(10): 915-919, 1995

Regioselective dibromination of methyl indole-3-carboxylate and application in the synthesis of 5,6-dibromoindoles. Organic & Biomolecular Chemistry 9(14): 5021-5023, 2011

Highly diastereoselective alkylation of aziridine-2-carboxylate esters: enantioselective synthesis of LFA-1 antagonist BIRT-377. Angewandte Chemie 44(38): 6169-6172, 2005

Regioselective alkylation and acylation of methyl 2 6 dideoxyhexopyranosides via their stannylene acetals key step for the synthesis of daunosamine and related aminosugars. Journal of Carbohydrate Chemistry 6(2): 221-230, 1987